Single molecule
structural fingerprinting lab
We are a research lab developing new optical tools to fingerprint the structure of single molecules in biological samples, to bridge atomic scale structural imaging, protein profiling, and human scale clinical diagnosis. We use these tools to advance research into the molecular and structural mechanisms of neurodegeneration.
We publish across a wide range of topics, from single-molecule and super-resolution microscopy to cell biology and neurodegeneration. For a comprehensive list of publications, visit our
google scholar →.
PloS Biology
Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease
Read paper →
Nature Communications
Co-aggregation with Apolipoprotein E modulates the function of Amyloid-ß in Alzheimer’s disease
Read paper →
Angewandte Chemie
Single-Molecule Characterization and Super-Resolution Imaging of Alzheimer's Disease-Relevant Tau Aggregates in Human Samples
Read paper →
Nature Protocols
Constructing a cost-efficient, high-throughput and high-quality single-molecule localization microscope for super-resolution imaging
Read paper →
Molecular Cell
The interplay between BAX and BAK tunes apoptotic pore growth to control mitochondrial-DNA-mediated inflammation
Read paper →
Nature Methods
Quantitative analysis of super-resolved structures using ASAP
Read paper →
PNAS
Dynamic label-free imaging of lipid nanodomains
Read paper →
Team
We are a multi-disciplinary team of physicists, chemists, engineers, and software developers working together to develop new single-molecule instrumentation, software, and assays to rewire structural biology and diagnostics to decode dementia and other complex biological processes.
John Danial
PI
PDRA, Cambridge and Tuebingen; D.Phil. in Chemistry, Oxford
Siqi Liu
Software developer
BSc in Computer Science, St Andrews
Sabrina Keating
Programmer
BSc (enroute) in Physics, St Andrews
Our work is multi-disciplinary, and so is our funding. We are grateful to our funders who are investing in the developing of cutting-edge technologies and their application to some of the toughest biological and health problems.